Muna Qayed retweeted
The Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta is hosting the 2025 Sickle Cell Transplant Advocacy & Research Alliance (STAR) Annual Meeting. We are honored to bring together hematologists and transplant physicians for this important 2-day event.
Muna Qayed retweeted
CONGRESS | #Tandem25
@MunaQayed, @EmoryUniversity discussed the impact of #GvHD on leukemia-free survival. In this study, GvHD did not reduce relapse risk in #ALL or #AML, and severe aGvHD led to inferior OS.
gvhdhub.com/medical-informat…
Muna Qayed retweeted
In the midst of an extremely difficult period, Lamya and I are walking to help support our university and the communities it serves. #AUB4BeirutRun2024
Muna Qayed retweeted
🎙️Had a great convo with @ASamerAlHomsi1 regarding the novel PTCy + abatacept + short course tacrolimus (#CAST regimen) - a potential game changer in #GVHD prophylaxis and perhaps next evolution of #PTCyRules.
Also first time hosting @ASTCT Talks! I hope you enjoy!🙏
podcasters.spotify.com/pod/s…
Muna Qayed retweeted
A validated risk stratification that incorporates MAGIC biomarkers predicts long-term outcome in pediatric patients with acute #GVHD. Biomarker-based risk stratification can be used in clinical trials to develop methods for children who require treatment. ow.ly/7ob650SeFy4
Muna Qayed retweeted
Ready to address barriers in #HCT and #celltherapy? Join us and @ASTCT on Oct. 17 to explore strategies to improve patient access and outcomes regardless of race, ethnicity or socioeconomic status. Plus, earn CME credit. Save your spot 👉 bit.ly/46qcuHq
Muna Qayed retweeted
#EBMT23 | @Razan_Mohty (@MoffittNews) discusses a study evaluating a novel composite endpoint of toxicity and PFS in patients with R/R follicular lymphoma treated with axi-cel.
Watch now:
👉ow.ly/cign50One8k👈
@TheEBMT #LymSM #CARTcell #ImmunoOnc
Muna Qayed retweeted
#ASPHO2033 #PHODocs #jobs
Come work with us at @ATLPedsHemOnc!
We are looking for:
- #BMT #Hospitalist
- #Cancer #Epidemiologist
- #Hemostasis/#Thrombosis #BasicScientist
- others!
👉CHOA.org/careers
Muna Qayed retweeted
Kicking of the 10th Annual @ThePTCTC educational meeting #ASPHO2023 #PTCTC2023 @RabiHannaMD " Diagnosing and treating pHLH and role of gammifant"
Muna Qayed retweeted
Thank you Krishna for your ongoing support and for sharing this. @SylvesterCancer @AAACTT_org #tandem23 @ASTCT
Congrats to @abeitin for presenting results of Tab-cel EBV-specific T cell therapy in #Tandem23 oral session. #tcellrx @ASTCT @CIBMTR #immunotherapy #IDTwitter #bmtsm
Muna Qayed retweeted
🌟 Dr @jean_yared presenting on Final Clinical Outcomes from a Phase 2 Trial of Posoleucel, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Prevention of Clinically Significant Viral Infections Post-HCT @ #Tandem23
tandem.confex.com/tandem/202…
Muna Qayed retweeted
TP-53 myeloid malignancies: Less relapse with cord based transplants vs MUD/MRD HCT suggesting more GVL? No difference in OS and PFS given higher TRM. How do we decrease TRM? #tandem23 poster 149
Muna Qayed retweeted
#bmt What's ur practice: severe Transplant Associated Thrombotic Microangiopathy (TA-TMA) re:CNI (calcineurin inhibitors) therapy & eculizumab (emab) @cdandoy1 @AkshaySharmaMD @SonataJodele @JJ_boelens @jamt941 @ouholter @BldCancerDoc @PrakashSatwani1 @TaniaJain11 @MunaQayed ?
15%Continue CNI +emab
24%Discontinue CNI+ emab
50%Replace CNI for siro+emab
12%Others (specify)
34 votes • Final results Muna Qayed retweeted
Guidelines for CAR-T Leukapheresis #cartcells sciencedirect.com/science/ar…
Muna Qayed retweeted
Thrilled to celebrate Drs. Sharmila Raghunandan and Sherri Smart for winning the #ASPHO2022 Early Career Travel Stipend Award.
Muna Qayed retweeted
One of the honors of my career has been the ability to be a member of the board of directors for @ASTCT. Thank you all for the opportunity!














































